72 reports

  • 12. MEA

Figure ##. ##.

  • Breast Cancer
  • Diagnostics
  • World
  • Forecast
  • Market Size

Certain medications for estrogen, contraceptive birth control pills, and high dosages of aspirin often impact the level of T##.

  • Diagnostics
  • Hospital
  • In Vitro Diagnostic Reagent
  • bioMerieux S.A.
  • Danaher Corporation
  • North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
  • CAGR 2012-2016

Long term usage of oral contraceptives : Research suggests that longer the usage of oral contraceptives (birth control pills) higher is the risk of cervical cancer.

  • Diagnostics
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • 4.1.1 ETIOLOGY
  • 5.7.1 EPIDEMIOLOGICAL FORECAST INSIGHT

Oral Contraceptive and Cancer Risks.

  • Breast Cancer
  • Diagnostics
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

It develops various product lines including vitamins, pregnancy tests, contraceptive products, and hair removers.

  • Diagnostics
  • World
  • Demographic
  • Alere Inc.
  • Church & Dwight Co., Inc.
  • 2.3 Etiology
  • 9.3 Bibliography

Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.

  • Breast Cancer
  • Diagnostics
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • GEOGRAPHIC ANALYSIS (15/29) EU-5

IS ONE OF THE MAJOR COMPANIES IN THE ISH MARKET.

  • Breast Cancer
  • Diagnostics
  • United States
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.

FIGURE ##-##: HEALTH EXPENDITURES, PUBLIC VS.

  • Breast Cancer
  • Diagnostics
  • Mexico
  • Becton Property Group
  • Roche Group

FIGURE ##-##: BRAZIL IN VITRO DIAGNOSTIC SALES BY MARKET SEGMENT, 2016-2021 ($ MILLIONS) Chapter ##: Executive Summary Consolidation in the Brazilian Laboratory Service Industry Is Stabilizing There are now four national, or regionally-dominate, laboratory service providers o

  • Breast Cancer
  • Diagnostics
  • Brazil
  • Alere Inc.
  • Becton Property Group
  • HUGE MARKET POTENTIAL FOR BREAST CANCER MABS OWING TO PRODUCT APPROVALS

For instance, the use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing breast cancer.

  • Breast Cancer
  • Diagnostics
  • Amgen Inc.
  • Mylan Inc.
  • Roche Group
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY

Combination hormone products, such as the estrogen + progestin contraceptive pill, have also been associated with an increased risk of breast cancer (NCI, 2016).

  • Breast Cancer
  • Diagnostics
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • 2.1.2 Causes of Breast Cancer

The Aptima HIV-## Quant assay is not approved for HIV-## diagnosis in the United States.

  • Breast Cancer
  • Diagnostics
  • World
  • Business Expansion & Exit
  • Hologic, Inc.
  • Breast Cancer Therapeutics Market, Taiwan, Market Size ($m), 2015-2022
  • Breast Cancer Therapeutics, South Korea, Age-Specific Incidence (%), 2012

Oral contraceptives and breast cancer risk in Taiwan, a country of low Journal of the National Cancer incidence of breast cancer and low use of oral contraceptives.

  • Breast Cancer
  • Diagnostics
  • Market Size
  • Genentech, Inc.
  • Novartis AG

For instance, the use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing breast cancer.

  • Breast Cancer
  • Diagnostics
  • World
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

ACTIVE INDUSTRY PLAYERS FIGURE ##. ## MICROBIOME THERAPEUTICS: ACTIVE INDUSTRY PLAYERS ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Phase I Phase I (planned) Preclinical Discovery Phase (Unknown) ## ##.

  • Diagnostics
  • North America
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC
  • 2.7.1 Epidemiological Forecast Insight

Chronic Diseases and Translational Medicine; ##(##): ##-##.

  • Breast Cancer
  • Diagnostics
  • China
  • United States
  • Forecast

One DALY can be interpreted as one lost year of healthy life.

  • Breast Cancer
  • Diagnostics
  • Market Size
  • Abbott Laboratories, Inc.
  • Medtronic, Inc.

You can easily book an appointment with one online.

  • Breast Cancer
  • Diagnostics
  • World
  • Bayer AG
  • Roche Group

Title Page No. ##.

  • Diagnostics
  • World
  • Abbott
  • ARKRAY, Inc.
  • Bayer AG

These include oral contraceptive use, multiple pregnancies and prolonged lactation.

  • Breast Cancer
  • Diagnostics
  • Market Size
  • Celgene Corporation
  • Merck & Co., Inc.
  • REFERRAL IS DICTATED BY STAGE AT DIAGNOSIS AND ELECTED TREATMENT APPROACH

Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, et al. (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.

  • Breast Cancer
  • Diagnostics
  • European Union
  • Japan
  • United States
  • 2.3 ETIOLOGY

Combination hormone products, such as the estrogen and progestin contraceptive pill, have also been associated with an increased risk of breast cancer (NCI, 2013).

  • Breast Cancer
  • Diagnostics
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Quartette is an oral contraceptive indicated for the prevention of pregnancy.

  • Breast Cancer
  • Hormone
  • United States
  • World
  • Product Initiative
  • NOV 14, 2017: FASLODEX (FULVESTRANT) RECEIVES EU APPROVAL FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER IN COMBINATION WITH PALBOCICLIB
  • DEC 06, 2017: H3 BIOMEDICINE PRESENTS PRECLINICAL DATA ON NOVEL ERA ANTAGONIST AT SAN ANTONIO BREAST CANCER SYMPOSIUM

We believe that Estelle has the potential to become a true ' next - generation' contraceptive option, including in North America, a market worth ##% of the USD ##bn worldwide contraceptive market.

  • Breast Cancer
  • Hormone
  • Hospital
  • Product Initiative
  • Mithra
  • 14. Market Growth Drivers

The use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing the disease.

  • Breast Cancer
  • Diagnostics
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

Lo LOESTRIN®remains the number one prescribed branded oral contraceptive.

  • Breast Cancer
  • Diagnostics
  • Pharmaceutical
  • United States
  • Merck & Co., Inc.
  • (ER+) breast cancer. The trial was registered with the U.S. National Institutes of Health.

Similarly, the universities portfolio in Phase II, Preclinical and Discovery stages comprises ##, ## and ## molecules, respectively.

  • Breast Cancer
  • Hormone
  • United States
  • World
  • Product Initiative
  • Untitled
  • FORECAST PERIOD

As a result, these trackers can be used both as a contraceptive and for ovulation prediction.

  • Diagnostics
  • North America
  • United States
  • Demographic
  • Prestige Brands Holdings, Inc.
  • Untitled
  • Untitled

It offers different types of contraceptives including mechanical barriers, chemical barriers and systemic contraceptives for both men and women.

  • Breast Cancer
  • Clinical Trial
  • Diagnostics
  • HIV AIDS
  • Novartis AG
  • MARKET DYNAMICS (2/10)
  • GLOBAL INCIDENCE OF BREAST CANCER, 2012-2025

This can majorly be attributed to changing lifestyles, increasing use of oral contraceptives, and the growing number of women undergoing cosmetic surgeries such as breast enhancement.

  • Breast Cancer
  • Diagnostics
  • North America
  • United States
  • Cianna Medical, Inc.